The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte

Hepatology

Volumn 29, Issue 4, 1999, Pages 1199-1207

  Taylor, Bradley S ^a,b   Liu, Shubing ^a   Villavicencio, Raphael T ^a   Ganster, Raymond W ^a   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENOSOBENZENE; CYTOKINE; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; OKADAIC ACID; PERVANADATE; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; TRANSLATION REGULATION;

EID: 0032929055     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290419     Document Type: Article

References (23)

1. Geller DA, Nussler AK, Di Silvio M, Lowenstein CL, Shapiro RA, Wang SC, Simmons RL, et al. A central role for interleukin-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase: IL-1β induces hepatic nitric oxide synthesis. J Immunol 1995;155:4890-4998.
2. Spitsin SV, Koprowski H, Micheals FH. Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-κB. Mol Med 1996;2:226-235.
3. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 1997;132:1177-1183.
4. de Vera ME, Taylor ES, Wang Q, Shapiro RA, Billiar TR, Geller DA. Dexamethasone suppresses inducible nitric oxide synthase gene expression by upregulating I-κBa and inhibiting NF-κB. Am J Physiol 1997;273:G1290-G1296.
5. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621-626.
6. Bohrer H, Qiu F, Zimmerman T. Role of NF-κB in the mortality of sepsis. J Clin Invest 1997;5:972-985.
7. Suzuki YJ, Forrnan HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269-285.
8. Chan TM, Chen E, Tatoyan A, Shargill NS, Pleta M, Hochstein P. Stimulation of tyrosine-specific protein phosphorylation in the rat liver plasma membrane by oxygen radicals. Biochem Biophys Res Commun 1986;139:439-445.
9. Larsson R, Cerutti P. Translocation and enhancement of phosphotranferase activity of protein kinase C following exposure in mouse epidermal cells to oxidants. Cancer Res 1989;49:5627-5632.
10. May MJ, Ghosh S. Signal transduction through NF-κB. Immunol Today 1998;19:80-88.
11. Brown K, Gerstberger S, Carlson L, Granzoso G, Sienblest U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 1995;267:1485-1488.
12. Didonato J, Mercurio F, Rosette C. Mapping of the inducible IκB phosphorylation sites that signal its ubiquination and degradation. Mol Cell Biol 1996;16:1295-1304.
13. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of IκBα requires site-specific ubiquination. Proc Natl Acad Sci U S A 1995;92:11259-11263.
14. Didonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997;388:548-554.
15. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett B, Li J, Young D, et al. IKK-1 and IKK-2: cytokine-activated 1κB kinases essential for NF-κB activation. Science 1997;281:860-866.
16. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an IκB kinase. Cell 1997;90:373-380.
17. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997;91:243-252.
18. Singh S, Aggarwal BB. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor dependent activation of the transcription factor NF-κB. J Biol Chem 1995;270:10631-10639.
19. Imbert V, Peyron JF, Farahi Far D, Mari B, Auberger P, Rossi B. Induction of tyrosine phosphorylation and T cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J 1994;297:163-173.
20. Sun SC, Maggirwar SB, Harhaj E. Activation of NF-κB by phosphatase inhibitors involves the phosphorylation of IκBα at phosphatase 2A-sensitive sites. J Biol Chem 1995;270:18347-18351.
21. Lin Y-C, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκBα: signal-induced phosphorylation of IκBα alone does not release active NF-κB. Proc Natl Acad Sci U S A 1995;92:552-556.
22. Thevenin C, Kim SJ, Rieckman P, Fujiki H, Norcross MA, Sporn MB, Fauci AS, et al. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol 1990;2:793-800.
23. Rieckmann P, Thevenin C, Kehrl JH. Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B lymphocytes. Biochem Biophys Res Commun 1992;187:51-57.